BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35465819)

  • 1. The performance of grey zone in common foetal aneuploidy screening by semiconductor sequencing.
    Zhang C; He Q; Qiao L; Li H; Wang T
    J Obstet Gynaecol; 2022 Aug; 42(6):1782-1787. PubMed ID: 35465819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
    Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
    Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the factors influencing positive predictive value of noninvasive prenatal testing for chromosome aneuploidies].
    Zhao GY; Dai P; Hu S; Jiao ZH; Kong XD
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2452-2457. PubMed ID: 36000375
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21.
    Yang J; Wu J; Wang D; Hou Y; Guo F; Zhang Q; Peng H; Wang Y; Yin A
    J Assist Reprod Genet; 2023 Apr; 40(4):803-810. PubMed ID: 36763299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant performances of non-invasive prenatal testing for foetal trisomy 21 screening in subgroups of pregnancies.
    Suo F; Wang Y; Wang N; Wang Y; Liao M; Wang J; Wang C; Zhang Y; Zhang M; Zhang C; Gu M; Gou L
    J Obstet Gynaecol; 2023 Dec; 43(2):2288226. PubMed ID: 38054928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
    Li Z; Duan H; Liu W; Zhu R; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):1-7. PubMed ID: 38171551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of true and false positive Z values among high-risk cases screened by non-invasive prenatal testing].
    Mo J; Ren J; Yang L; Shen X; Zhao D; Xiao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1187-1191. PubMed ID: 36317201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy.
    Kim S; Jung H; Han SH; Lee S; Kwon J; Kim MG; Chu H; Chen H; Han K; Kwak H; Park S; Joo HJ; Kim BC; Bhak J
    BMC Med Genomics; 2016 Apr; 9(1):22. PubMed ID: 27129388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Application and Accuracy Evaluation of Noninvasive Prenatal Testing for Common Trisomy and Sex Chromosome Aneuploidy.
    Wang Y; Shao Y; Yu J
    Discov Med; 2023 Jun; 35(176):353-360. PubMed ID: 37272102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.